An international panel of healthcare stakeholders recently released consensus recommendations for the use of biosimilars in the treatment of rheumatic diseases. Learn more about what that panel recommended.
Industry news
An international panel of healthcare stakeholders recently released consensus recommendations for the use of biosimilars in the treatment of rheumatic diseases. Learn more about what that panel recommended.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.